Antipsychotics prescribing patterns of patients with schizophrenia admitted to Korean General Hospital Psychiatric Unit: 2001 to 2008

Clinical Psychopharmacology and Neuroscience

Volumn 9, Issue 1, 2011, Pages 17-22

  Choi, Hye Jin ^a   Jung, Seung Ho ^a   Kang, Min Hee ^a   Lee, Jeong Seop ^a   Bae, Jae Nam ^a   Kim, Chul Eung ^a  

^a Inha University School of Medicine   (South Korea)

Author keywords

Antipsychotic monotherapy; Polypharmacy; Schizophrenia

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ADULT; ARTICLE; COMPARATIVE STUDY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; POLYPHARMACY; PRESCRIPTION; SCHIZOPHRENIA;

EID: 79955768015     PISSN: 17381088     EISSN: None     Source Type: Journal    
DOI: 10.9758/cpn.2011.9.1.17     Document Type: Article

References (30)

1. Treatment of schizophrenia. The expert consensus guideline series. J Clin Psychiatry 1999;60(Suppl 11):3-80.
2. Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, et al. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry 2004;161(2 Suppl):1-56.
3. National Institute for Mental Health in England. Available from: http://www.schizophreniaguidelines.co.uk/.
4. Kim W, Bahk WM, Woo YS, Seo HJ, Jun TY, Kim KS, et al. Polypharmacy in schizophrenic inpatients: The comparison between 1997 and 2003 in one university hospital. Korean J Psychopharmacol 2005;16:390-395.
5. Faries D, Ascher-Svanum H, Zhu B, Correll C, Kane J. Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics. BMC Psychiatry 2005;5:26.
6. Megna JL, Kunwar AR, Mahlotra K, Sauro MD, Devitt PJ, Rashid A. A study of polypharmacy with second generation antipsychotics in patients with severe and persistent mental illness. J Psychiatr Pract 2007;13:129-137.
7. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005;353:1209-1223.
8. Shiloh R, Nutt DJ, Weizman A. Atlas of psychiatric pharmacotherapy. Rev. ed. London:Martin Dunitz;2000.
9. Chong MY, Tan CH, Fujii S, Yang SY, Ungvari GS, Si T, et al. Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change. Psychiatry Clin Neurosci 2004;58:61-67.
10. Kim DJ, Ahn YM, Kang DY, Kim SH, Kim CY, Min KJ, et al. Korean Medication Algorithm Projects for major psychiatric disorders (II): background, basic Plan, organization of KMAP and principles, methods of algorithm development and limitation, Caution when sing KMAP. Korean J Psychopharmacol 2002;13:30-36.
11. Ahn YM, Kwon JS, Bahk WM, Kim CE, Park JI, Lee SY, et al. The feasibility test of Korean Medication Algorithm for the treatment with Schizophrenic patients (II): The problem for applying algorithm to the real clinical situation and opinion of revision. Korean J Psychopharmacol 2006;17:35-49.
12. Rittmannsberger H, Meise U, Schauflinger K, Horvath E, Donat H, Hinterhuber H. Polypharmacy in psychiatric treatment. Patterns of psychotropic drug use in Austrian psychiatric clinics. Eur Psychiatry 1999;14:33-40.
13. Wang PS, West JC, Tanielian T, Pincus HA. Recent patterns and predictors of antipsychotic medication regimens used to treat schizophrenia and other psychotic disorders. Schizophr Bull 2000;26:451-457.
14. Procyshyn RM, Kennedy NB, Tse G, Thompson B. Antipsychotic polypharmacy: a survey of discharge prescriptions from a tertiary care psychiatric institution. Can J Psychiatry 2001;46:334-339.
15. McCue RE, Waheed R, Urcuyo L. Polypharmacy in patients with schizophrenia. J Clin Psychiatry 2003;64:984-989.
16. Sim K, Su A, Fujii S, Yang SY, Chong MY, Ungvari GS, et al. Antipsychotic polypharmacy in patients with schizophrenia: a multicentre comparative study in East Asia. Br J Clin Pharmacol 2004;58:178-183.
17. Waring EW, Devin PG, Dewan V. Treatment of schizophrenia with antipsychotics in combination. Can J Psychiatry 1999;44:189-190.
18. Kennedy NB, Procyshyn RM. Rational antipsychotic polypharmacy. Can J Clin Pharmacol 2000;7:155-159.
19. Rhoads E. Polypharmacy of 2 atypical antipsychotics. J Clin Psychiatry 2000;61:678-680.
20. Taylor CG, Flynn SW, Altman S, Ehmann T, MacEwan GW, Honer WG. An open trial of risperidone augmentation of partial response to clozapine. Scizophr Res 2001;48:155-158.
21. Ito H, Koyama A, Higuchi T. Polypharmacy and excessive dosing: psychiatrists' perceptions of antipsychotic drug prescription. Br J Psychiatry 2005;187:243-247.
22. Stahl SM, Grady MM. A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation. Curr Med Chem 2004;11:313-327.
23. Raskin S, Katz G, Zislin Z, Knobler HY, Durst R. Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation. Acta Psychiatr Scand 2000;101:334-336.
24. Lerner V, Chudakova B, Kravets S, Polyakova I. Combined use of risperidone and olanzapine in the treatment of patients with resistant schizophrenia: a preliminary case series report. Clin Neuropharmacol 2000;23:284-286.
25. Centorrino F, Goren JL, Hennen J, Salvatore P, Kelleher JP, Baldessarini RJ. Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits. Am J Psychiatry 2004;161:700-706.
26. Freudenreich O, Goff DC. Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations. Acta Psychiatr Scand 2002;106:323-330.
27. Shinfuku N, Tan CH. Pharmacotherapy for schizophrenic inpatients in East Asia - changes and challenges. Int Rev Psychiatry 2008;20:460-468.
28. Casey DE, Daniel DG, Wassef AA, Tracy KA, Wozniak P, Sommerville KW. Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia. Neuropsychopharmacology 2003;28:182-192.
29. Swainston Harrison T, Perry CM. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder. Drugs 2004;64:1715-1736.
30. Andersen SE, Johansson M, Manniche C. The prescribing pattern of a new antipsychotic: a descriptive study of aripiprazole for psychiatric in-patients. Basic Clin Pharmacol Toxicol 2008;103:75-81.